Sunday, May 19, 2024

PaJR CGM case report 80F Diabetes,hypertension, hypothyroidism 30 years, neuropathy 2 years Karnataka

 Born March 1944


Hypothyroidism (TSH 100 in 1990)

Diabetes, Hypertension since 2000

Neuropathy with gait ataxia 2 years


Multiple UTIs and most recent on May 2024 


Was on 

1.Glimeperide 4 mg twice daily 

2. AMTAS AT Amlodipine and Atenolol once daily 

3.  GLYCIPHAGE metformin 500 mg once daily 

4. TRIKA alprazolam 0.25 once at bedtime 

5. Thyroxine 100 mcg once daily

 Till recently


HbA1c 8.55 on  6 May 2024 

Started on CGM since 19/5/24 for stringent glucose control toward preventing UTI when unexpectedly found to have hypoglycemias since today after 4 mg of Glimeperide in the morning (which she has been regularly consuming since few years now) 



Summary of PaJR transcripts in October 2024:

On CGM monitoring, the insights obtained for this particular patient was that she was having recurrent hypoglycemia and her glimiperide doses were well optimised to prevent the hypoglycemic episodes and currently the patient's sugar control till 28 August 2024 showed an impeccable Hba1c of 7.2




No comments: